» Authors » Gregory M Lucas

Gregory M Lucas

Explore the profile of Gregory M Lucas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 161
Citations 3267
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaptchuk R, Kant A, Shekhawat S, Baishya J, Sinha A, Kedar A, et al.
Harm Reduct J . 2025 Mar; 22(1):32. PMID: 40087767
Background: People who inject drugs (PWID) experience a higher burden of HIV compared to general populations. Social support has been shown to improve disease management and combat stigma for PWID...
2.
McFall A, Ganapathi L, Gunaratne M, Srikrishnan A, Vasudevan C, Anand S, et al.
Addiction . 2024 Nov; 120(4):745-755. PMID: 39604070
Aims: The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association...
3.
Gonzalez Corro L, Lucas G, Page K
Open Forum Infect Dis . 2024 Nov; 11(11):ofae661. PMID: 39582499
There are an estimated 3.5 million people with hepatitis C virus (HCV) infection in the United States, resulting in 15 000 HCV-related deaths in 2019 and approximately $7 billion annually...
4.
Mehta S, Lau B, Ehrhardt S, McFall A, Gunaratne M, Baishya J, et al.
Am J Epidemiol . 2024 Nov; PMID: 39572371
Efforts to eliminate hepatitis C virus (HCV) as a public health problem must include people who inject drugs (PWID). We describe the design and baseline characteristics of the Supporting Treatment...
5.
Verinumbe T, Lucas G, Zook K, Weir B, Landry M, Page K, et al.
Drug Alcohol Depend Rep . 2024 Nov; 13:100288. PMID: 39498373
Background: Perceived HIV risk may impact willingness to initiate PrEP among people who inject drugs (PWID). Methods: We analyzed baseline data from PrEP eligible PWID in Baltimore, MD. Risk perception...
6.
Ramirez M, Lucas G, Page K, Zook K, Landry M, Rosecrans A, et al.
Drug Alcohol Depend Rep . 2024 Oct; 13:100286. PMID: 39430605
Background: Longitudinal studies of future overdose risk among people who inject drugs (PWID) are needed to inform planning of targeted overdose preventions in the United States. Methods: The Integrating Services...
7.
Karimi-Sari H, Lucas G, Zook K, Weir B, Landry M, Sherman S, et al.
Viruses . 2024 Sep; 16(9). PMID: 39339891
Background: Hepatitis C virus (HCV) infection and hazardous alcohol use are both preventable causes of morbidity and mortality among people who inject drugs (PWID). In the general population, hazardous alcohol...
8.
McFall A, Gunaratne M, Ganapathi L, Srikrishnan A, Vasudevan C, Anand S, et al.
J Int AIDS Soc . 2024 Sep; 27(9):e26361. PMID: 39301675
Introduction: Globally, there have been significant declines in HIV incidence over the past two decades, but this decline is slowing, and in some settings, declines have stalled or are growing-particularly...
9.
Ganapathi L, Srikrishnan A, McFall A, Gunaratne M, Kumar M, Lucas G, et al.
Harm Reduct J . 2024 Sep; 21(1):170. PMID: 39272091
Background: Over the last decade, India has had an alarming rise in injection of opioids across several cities. Although scale-up of public sector services for people who inject drugs (PWID)...
10.
Loeb T, Gunaratne M, Iqbal S, Anderson M, McFall A, Amrose P, et al.
Open Forum Infect Dis . 2024 Jul; 11(7):ofae350. PMID: 39022392
Background: People with HIV (PWH) who are coinfected with hepatitis B virus (HBV) have a higher risk of mortality compared with PWH alone. Populations such as people who inject drugs...